首页 › 非小细胞肺癌 › 纽约州 › New Rochelle
New Rochelle NY 非小细胞肺癌临床试验
18项针对 非小细胞肺癌的研究正在 New Rochelle及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- The Cancer Institute at Saint Francis Hospital, East Hills · 距离 11 英里
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距离 5 英里
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
招募中1 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Using Urine Samples to Identify Lung Cancer
招募中观察性研究欢迎健康志愿者
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
招募中2 期
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison · 距离 5 英里
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
招募中
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- Memorial Sloan Kettering Westchester, Harrison · 距离 5 英里
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距离 5 英里
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
招募中观察性研究
- Memorial Sloan Kettering Westchester (Consent Only), Harrison · 距离 5 英里
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距离 5 英里
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
招募中2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距离 5 英里
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距离 5 英里
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
招募中2 期
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 距离 5 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Manhasset · 距离 9 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
New Rochelle的其他研究
- 乳腺癌38 项研究
- 前列腺癌16 项研究
- 多发性骨髓瘤14 项研究
- 急性髓系白血病13 项研究
- 膀胱癌11 项研究
- 肺癌11 项研究
- 子宫内膜癌11 项研究
- 转移性癌症10 项研究
- 癌症（所有类型）10 项研究
- 卵巢癌9 项研究
- 心血管疾病8 项研究
- 胰腺癌8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。